Lv Y - Search Results

1

Preliminary screening of differentially expressed genes involved in methyl-CpG-binding protein 2 gene-mediated proliferation in human osteosarcoma cells.

Meng G, Li Y, Lv Y, Dai H, Zhang X, Guo QN. Meng G, et al. Among authors: lv y. Tumour Biol. 2015 Apr;36(4):3009-15. doi: 10.1007/s13277-014-2935-4. Epub 2015 Jan 23. Tumour Biol. 2015. PMID: 25613065

2

Epigenetic regulation of the pro-apoptosis gene TSSC3 in human osteosarcoma cells.

Li Y, Huang Y, Lv Y, Meng G, Guo QN. Li Y, et al. Among authors: lv y. Biomed Pharmacother. 2014 Feb;68(1):45-50. doi: 10.1016/j.biopha.2013.10.006. Epub 2013 Oct 18. Biomed Pharmacother. 2014. PMID: 24268429

3

Endothelial cells promote stem-like phenotype of glioma cells through activating the Hedgehog pathway.

Yan GN, Yang L, Lv YF, Shi Y, Shen LL, Yao XH, Guo QN, Zhang P, Cui YH, Zhang X, Bian XW, Guo DY. Yan GN, et al. Among authors: lv yf. J Pathol. 2014 Sep;234(1):11-22. doi: 10.1002/path.4349. Epub 2014 Jun 18. J Pathol. 2014. PMID: 24604164 Free PMC article.

4

Epigenetic silencing of methyl-CpG-binding protein 2 gene affects proliferation, invasion, migration, and apoptosis of human osteosarcoma cells.

Meng G, Lv Y, Dai H, Zhang X, Guo QN. Meng G, et al. Among authors: lv y. Tumour Biol. 2014 Dec;35(12):11819-27. doi: 10.1007/s13277-014-2336-8. Epub 2014 Sep 17. Tumour Biol. 2014. PMID: 25227661

5

Enhancer of zeste homolog 2 silencing inhibits tumor growth and lung metastasis in osteosarcoma.

Lv YF, Yan GN, Meng G, Zhang X, Guo QN. Lv YF, et al. Sci Rep. 2015 Aug 12;5:12999. doi: 10.1038/srep12999. Sci Rep. 2015. PMID: 26265454 Free PMC article.

6

Advances in osteosarcoma stem cell research and opportunities for novel therapeutic targets.

Yan GN, Lv YF, Guo QN. Yan GN, et al. Cancer Lett. 2016 Jan 28;370(2):268-74. doi: 10.1016/j.canlet.2015.11.003. Epub 2015 Nov 10. Cancer Lett. 2016. PMID: 26571463 Free article. Review.

7

Downregulation of tumor suppressing STF cDNA 3 promotes epithelial-mesenchymal transition and tumor metastasis of osteosarcoma by the Wnt/GSK-3β/β-catenin/Snail signaling pathway.

Lv YF, Dai H, Yan GN, Meng G, Zhang X, Guo QN. Lv YF, et al. Cancer Lett. 2016 Apr 10;373(2):164-73. doi: 10.1016/j.canlet.2016.01.046. Epub 2016 Feb 1. Cancer Lett. 2016. PMID: 26845447

8

The risk of new-onset cancer associated with HFE C282Y and H63D mutations: evidence from 87,028 participants.

Lv YF, Chang X, Hua RX, Yan GN, Meng G, Liao XY, Zhang X, Guo QN. Lv YF, et al. J Cell Mol Med. 2016 Jul;20(7):1219-33. doi: 10.1111/jcmm.12764. Epub 2016 Feb 19. J Cell Mol Med. 2016. PMID: 26893171 Free PMC article.

9

RanBP9/TSSC3 complex cooperates to suppress anoikis resistance and metastasis via inhibiting Src-mediated Akt signaling in osteosarcoma.

Dai H, Lv YF, Yan GN, Meng G, Zhang X, Guo QN. Dai H, et al. Cell Death Dis. 2016 Dec 29;7(12):e2572. doi: 10.1038/cddis.2016.436. Cell Death Dis. 2016. PMID: 28032865 Free PMC article.

10

TSSC3 represses self-renewal of osteosarcoma stem cells and Nanog expression by inhibiting the Src/Akt pathway.

Yan GN, Tang XF, Zhang XC, He T, Huang YS, Zhang X, Meng G, Guo DY, Lv YF, Guo QN. Yan GN, et al. Oncotarget. 2017 Aug 24;8(49):85628-85641. doi: 10.18632/oncotarget.20429. eCollection 2017 Oct 17. Oncotarget. 2017. PMID: 29156746 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,025 results

Search Page

Filters